An Exploratory Analysis of Alendronate in Older Men with Low Glomerular Filtration Rate

Abstract Bisphosphonates are not recommended for patients with a creatinine clearance less than 35 ml/minute, yet many individuals with osteoporosis have reduced renal function. We performed a retrospective case-control study to explore the effects of alendronate on bone mass in such individuals. Ca...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of aging & pharmacotherapy 2006, Vol.13 (2), p.21-33
Hauptverfasser:	Hansen, K. E., Hofmann, R. M., Drake, R. K., Argall, T. R., Bier, H. A., Grigg, K. T., Rouse, E. D., Elliott, M. E.
Format:	Artikel
Sprache:	eng
Schlagworte:	bisphosphonate bone density osteoporosis Renal osteodystrophy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!